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Mature cystic teratoma is a common benign neoplasm of the ovary. Complications occur in approximately 20% of
cases. Clinical manifestations, laboratory findings, and imaging studies can assist in making a diagnosis of ovarian
torsion of mature cystic teratoma. Furthermore, serum tumor markers may be helpful for diagnosing mature cystic
teratoma and its torsion and, thus, can lead to early surgical intervention. A 56-year-old woman presented with a
huge pelvic mass and pelvic pain. Serum CA19-9, CA125, and carcinoembryonic antigen levels were abnormally
elevated at >700 U/ml, 282.5 U/ml, and 3.94 U/ml, respectively. The tumor was surrounded by extensive adhesions
and showed inflammatory changes. The serum levels of these markers returned to normal levels after surgery.
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Mature cystic teratoma (MCT) is the most common
germ cell tumor of the ovary in women of reproductive
age. Clinical characteristics of MCT have been well doc-
umented, and about 20% of women with MCT experi-
ence complications, such as torsion, rupture, infection,
and malignant transformation. Ovarian torsion is a com-
mon complication and constitutes a surgical emergency,
and the rate of torsion has been reported to range from
12.9% to 15% in MCT patients [1,2]. Furthermore, ovar-
ian torsion accounts for 3% of cases of acute abdominal
pain that present at emergency departments [3]. Delay
in recognition and treatment of torsion can have serious
consequences such as peritonitis and even death [4]. La-
boratory and imaging findings can assist the diagnosis of
MCT and its complications, and serum tumor markers
can provide additional information about the clinical
features and complications of MCT when the differential
diagnosis of an ovarian mass by imaging is limited.* Correspondence: ghkim@pusan.ac.kr
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unless otherwise stated.Here we report a case of ovarian torsion of MCT with
rapid, significant changes in the serum levels of CA19-9
and CA125 in a postmenopausal woman.Case presentation
A 56-year-old postmenopausal woman presented with
a huge pelvic mass. The patient had experienced mod-
erate pelvic pain for 5 days before visiting a local clinic.
Pelvic ultrasonography revealed a huge mass 11 cm in
diameter in the right adnexa. Contrast-enhanced ab-
dominopelvic computed tomography (CT) revealed an
11.0 × 7.5 cm mass containing a fat component arising
from the right adnexa. She was referred to our hospital
department due to abnormally high tumor markers and
suspicion of a coexistent malignancy due to elevated
serum CA19-9, CA125, and carcinoembryonic antigen
(CEA) levels of >700 U/ml, 282.5 U/ml, and 3.94 U/ml,
respectively. These serum markers were measured
again preoperatively in our hospital and were found to
be higher (Figure 1). Laboratory examination revealed
increased white blood cell count (18,500/uL) and
erythrocyte sedimentation rate (90 mm/hour). Previous
CT findings were reviewed and showed asymmetric
wall thickening of the mass and increased fat strands in
peritoneum. During laparotomy, a huge right ovarian
tumor that appeared dark brown presumably due to. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Perioperative changes in serum tumor makers. CA19-9,
CA125, and carcinoembryonic antigen (CEA) levels (U/ml) were
highly elevated preoperatively, but returned to normal levels after
surgery. POD, postoperative day; preop, preoperative.
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adhesions to omentum, rectum, and the posterior wall
of the uterus. The surface of the tumor was friable,
discolored, and had an irregular contour, suggesting
inflammatory change, probably due to torsion-induced
necrosis (Figure 2). Right salpingo-oophorectomy was
performed and adjacent adherent omentum was ex-
cised. Frozen section of the tumor revealed MCT.
Pathologically, most of the tumor was necrotic and
compatible with MCT with hemorrhagic infarction and
chronic inflammation of omentum. Following surgery
the patient recovered without any complications, and
serum levels of CA19-9, CA125, and CEA decreased to
normal levels (Figure 1).Discussion
MCT is the most common benign neoplasm of the
ovary. Adnexal torsion is a gynecologic surgical emer-
gency, as delay in surgical treatment may lead to serious
inflammatory consequences [4]. Sometimes the diagnosis
of torsion is not straightforward because symptoms are
nonspecific. Acute pelvic pain in torsion may be con-
stant or intermittent depending on the degree of torsion.
The episodes of pain can occur for several days to
months prior to definitive treatment. In cases of partial
torsion, there may be a history of similar transient
episodes of pain. Furthermore, the pain can vary in
intensity and may not be severe. If torsion is prolonged
and treatment delayed, the adnexa may become necrotic
and infected, and the patient may present with signs of
peritonitis [5]. Some authors have concluded that the
time between pain onset and definitive treatment is a
marker of necrosis. Chen and colleagues showed that
extensive hemorrhagic necrotic cases had torsion dura-
tions of 48 hours or longer [6], whereas Emonts and col-
leagues reported a median time from onset of pain until
surgery of 5.3 days in patients with microscopic necrosis
[7]. In our case, the patient first visited hospital 5 days
after the onset of pain because the pain was tolerable,
and surgery was performed 12 days after the onset of
pain. The mass was found to be surrounded by extensive
adhesions and the tumor surface exhibited inflammatory
changes. The abnormally high serum tumor markers in
our patient were probably due to prolonged torsion and
subsequent peritoneal inflammation.
Ultrasonography is usually used for the diagnosis of
ovarian MCT. However, accurate diagnosis is difficult
because tumor contents vary. In addition, 80% of cystic
teratomas have sonographic appearances similar to those
of ovarian malignancies [8]. Therefore, the diagnosis of
ovarian MCT requires additional diagnostic aids, such as
tumor markers. Furthermore, some of tumor markers
may be helpful in the diagnosis of torsion and, thus, lead
to prompt treatment.
The rates of elevation of CA19-9 and CA125 have
been reported to be 39.6 to 59% and 13.5 to 25%, re-
spectively [1,9,10]. Emin and colleagues showed that
CA19-9 is more frequently elevated than CA125, and
hence a more useful marker of MCT [10]. On the other
hand, CA19-9 is a widely used tumor marker for various
malignancies, and is usually increased in gastrointestinal
tumors. CA19-9 levels may have clinical significance in
MCT of the ovary, and are not significantly related to
age, body mass index, bilaterality, or serum CA125 levels
[1]. Furthermore, elevated CA19-9 levels may be import-
ant for the diagnosis of MCT and appear to be corre-
lated with tumor diameter [1,11,12], and the extent of
tissue necrosis due to ovarian torsion [1,2]. Kyung and
colleagues demonstrated that serum CA19-9 levels in
Figure 2 Operative finding of right ovarian tumor showing a friable, discolored, and irregularly contoured surface.
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those without torsion [1]. Previous studies have demon-
strated that malignant transformation is not related to
serum CA19-9 elevation, and that elevated CA19-9
levels in women with MCT of the ovary are not associ-
ated with malignant transformation [13].
CA125 is an extensively studied marker in the context
of ovarian tumors. Serum CA125 levels provide infor-
mation preoperatively that aid discrimination of benign
and malignant adnexal masses. However, CA125 is
not a tumor-specific antigen, and is also elevated in
patients with endometriosis, adenomyosis, leiomyoma,
and pelvic inflammatory disease. Accordingly, know-
ledge of CA125 alone is unhelpful for the diagnosis of
MCT, and elevated CA125 levels in MCT may be re-
lated to peritoneal inflammation, such as that associated
with pelvic inflammatory disease. In our case, the
CA125 elevation was probably caused by torsion and in-
flammatory processes.
CA19-9, in combination with CA125, might be a use-
ful marker for the discrimination of MCT from ovarian
cancer [12]. In a retrospective study of 239 patients with
ovarian MCT, it was found that elevation of CA19-9
alone was more frequent in patients with MCT than
ovarian cancer, and that the simultaneous elevation of
CA19-9 and CA125 was associated with a higher prob-
ability of a malignant neoplasm [12]. In another study,
Fujiwara and colleagues observed that CA125 and
CA19-9 levels increased dramatically prior to surgery
following torsion of an ovarian tumor [14]. Our case
showed simultaneous elevation of CA19-9 and CA125
that was not associated with ovarian malignancy; rather,they appeared to be associated with torsion of the ovary
and resulting peritoneal inflammation.
The rate of elevation of CEA in ovarian MCT has been
reported to range from 9.1 to 16.3% [9-11]. However, it
is of little significance in MCT [9,11].
Nevertheless, these three serum markers can provide
valuable information for the diagnosis of MCT and for
predicting its complication, although CA125 or CA19-9
testing is not sufficient for the diagnosis of MCT [10].
Our case suggests that concurrent abnormal elevations
of CA19-9 and CA125 are manifestations of torsion
of the ovary and subsequent necrosis and inflammation,
which is consistent with the observations made in pre-
vious studies [2,14]. The relationship between tumor
markers and inflammation/ischemia has not been well
documented. Only a few reports suggested that CA19-9
might have been stimulated by the inflammatory change
due to the ischemic reaction after torsion and might
predict the extent of tissue necrosis [2,14]. The role of
ischemia and necrosis was not fully defined. Further
studies are needed to confirm the biochemical mecha-
nisms of elevation of these markers.
In our case, prolonged torsion and delayed treatment
were caused by a number of factors. First, symptoms were
nonspecific, which delayed hospital visit. Second, the first
gynecologist approached at the primary clinic under-
interpreted CT findings and over-interpreted serum tumor
marker findings. In particular, CT findings suggesting
adnexal torsion and high tumor markers were interpreted
as indicators of ovarian malignancy. Third, delayed referral
to a tertiary center was attributed to adherence to a rou-
tine outpatient schedule.
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In conclusion, a highly elevated serum CA19-9 level may
be an adjunct serum marker for the diagnosis of ovarian
teratoma, and could also provide useful information on
the presence of torsion. Furthermore, simultaneous eleva-
tions of CA19-9 and CA125 are not always associated
with malignancy and may improve the detection of torsion
and the prediction of the extent of necrosis. Perioperative
assessment of tumor markers may provide valuable infor-
mation on the progression or resolution of inflammatory
processes following torsion of the ovary. The interpret-
ation of tumor marker elevations should be made in light
of the clinical condition. The dramatic changes in serum
markers observed perioperatively in our patient gave us a
better understanding of the inflammatory process follow-
ing prolonged ovarian torsion.
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